MERCAPT mercaptopurine monohydrate 50 mg tablet bottle

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

有効成分:

mercaptopurine monohydrate, Quantity: 50 mg

から入手可能:

Aspen Pharmacare Australia Pty Ltd

INN（国際名）:

mercaptopurine monohydrate

医薬品形態:

Tablet, uncoated

構図:

Excipient Ingredients: lactose monohydrate; maize starch; stearic acid; magnesium stearate; hydrolysed maize starch

投与経路:

Oral

パッケージ内のユニット:

25 tablets

処方タイプ:

(S4) Prescription Only Medicine

適応症:

INDICATIONS AS AT 5 March 2004: Treatment of leukemia. It is of value in remission induction and is particularly indicated for maintenance therapy in acute lymphoblastic leukemia and acute myelogenous leukemia. MERCAPT is also used in the treatment of chronic granulocytic leukaemia.

製品概要:

Visual Identification: Pale yellow, round, biconvex tablets, marked PT above the line and 50 below the line on one side and plain on the other.; Container Type: Bottle; Container Material: Glass; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

認証ステータス:

Licence status A

承認日:

2017-09-21